SFR8-B6細(xì)胞
數(shù)量: 大量
細(xì)胞形態(tài): **樣
**類型: IgG2b
運(yùn)輸方式: 凍存運(yùn)輸
生長狀態(tài): 懸浮生長
ATCC Number: HB-152?
是否是腫瘤細(xì)胞: 0
物種來源: 大鼠
Designations: SFR8-B6
Depositors: SF Radka
Isotype: IgG2b
SFR8-B6細(xì)胞Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: suspension
Organism: Rattus norvegicus (B cell); Mus musculus (myeloma) deposited as rat (B cell); mouse (myeloma)
Morphology: lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products: immunoglobulin; monoclonal antibody; against HLA Bw6
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. SFR8-B6細(xì)胞Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments: Animals were immunized with partially purified glycoprotein preparations from detergent solubilized membranes from the JY human lymphoblastoid cell line.
Popliteal lymph node cells were fused with Sp2/0-Ag14 myeloma cells.
Tested and found negative for ectromelia virus (mousepox).
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC Hybri-Care Medium, Catalog No. 46-X. Hybri-Care Medium is supplied as a powder and should be reconstituted in 1 L cell-culture-grade water. To make the complete growth medium, add the following components to the base medium:
SFR8-B6細(xì)胞fetal bovine serum to a final concentration of 10%
1.5 g/L sodium bicarbonate for use with 5% CO2 in air atmosphere.
Temperature: 37.0°C
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
References: 1002: Radka SF, et al. A monoclonal antibody directed against the HLA-BW6 epitope. J. Immunol. 128: 2804-2806, 1982. PubMed: 6176653
32497: White CA, et al. Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells. Int. J. Cancer 75: 590-595, 1998. SFR8-B6細(xì)胞PubMed: 9466661